Wells Fargo Upgrades Equitrans Midstream to Overweight, Announces $13 Price Target
Wells Fargo analyst Michael Blum upgrades Equitrans Midstream (NYSE:ETRN) from Equal-Weight to Overweight and announces $13 price target.
Berenberg Upgrades Cazoo Gr to Buy, Raises Price Target to $2.33
Berenberg analyst Saim Saeed upgrades Cazoo Gr (NYSE:CZOO) from Sell to Buy and raises the price target from $0.49 to $2.33.
Cantor Fitzgerald Upgrades Inspirato to Overweight, Announces $8 Price Target
Cantor Fitzgerald analyst Brett Knoblauch upgrades Inspirato (NASDAQ:ISPO) from Neutral to Overweight and announces $8 price target.
BMO Capital Upgrades Brunswick to Outperform, Raises Price Target to $110
BMO Capital analyst Gerrick Johnson upgrades Brunswick (NYSE:BC) from Market Perform to Outperform and raises the price target from $90 to $110.
Barrington Research Upgrades PowerFleet to Outperform
Barrington Research analyst Gary Prestopino upgrades PowerFleet (NASDAQ:PWFL) from Market Perform to Outperform.
Why This Teva Pharmaceuticals Analyst Is Turning Bullish ‘The Most Room To Re-Rate’
Following Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) opioid settlement, the Tel Aviv-Yafo, Israel-based company seems to be making “material progress” in clearing its litigation overhangs.
Maxim Group Upgrades Joint to Buy, Announces $36 Price Target
Maxim Group analyst Anthony Vendetti upgrades Joint (NASDAQ:JYNT) from Hold to Buy and announces $36 price target.
Wedbush Upgrades Cavco Indus to Outperform, Raises Price Target to $385
Wedbush analyst Jay McCanless upgrades Cavco Indus (NASDAQ:CVCO) from Neutral to Outperform and raises the price target from $315 to $385.
JMP Securities Upgrades Deciphera Pharmaceuticals to Market Outperform, Announces $23 Price Target
JMP Securities analyst Reni Benjamin upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Market Perform to Market Outperform and announces $23 price target.
Raymond James Upgrades Essex Property Trust to Outperform, Announces $300 Price Target
Raymond James analyst Buck Horne upgrades Essex Property Trust (NYSE:ESS) from Market Perform to Outperform and announces $300 price target.